Hanx Biopharmaceuticals (Wuhan) Co., Ltd. enterprise value

The Enterprise Value as of October 2026 (TTM) for Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) is 12.06B

According to Hanx Biopharmaceuticals (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.06B. This represents a change of 49.80% compared to the average of 8.05B of the last 4 quarters.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Historical Enterprise Value (quarterly & annually)

How has 3378.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. over the last ten years is 43.29B. The current 12.06B Enterprise Value has changed -72.15% with respect to the historical average. Over the past ten years (40 quarters), 3378.HK's Enterprise Value was at its highest in in the June 2019 quarter at 47.06B. The Enterprise Value was at its lowest in in the September 2010 quarter at 0.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Average Enterprise Value

How has 3378.HK Enterprise Value performed in the past?

The current Enterprise Value of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Enterprise Value vs. Peers

How is 3378.HK’s Enterprise Value compared to its peers?

Hanx Biopharmaceuticals (Wuhan) Co., Ltd.’s Enterprise Value is greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (749.11M), greater than Alphamab Oncology (5.34B), greater than InnoCare Pharma Limited (11.88B), greater than Antengene Corporation Limited (1.05B), greater than CStone Pharmaceuticals (5.55B), less than Akeso, Inc. (64.03B), greater than Lepu Biopharma Co., Ltd. (6.49B), greater than TYK Medicines, Inc (992.40M), greater than 3D Medicines Inc. (572.06M), greater than Ascentage Pharma Group International (9.82B),

Build a custom stock screener for Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hanx Biopharmaceuticals (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hanx Biopharmaceuticals (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.